JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6 | -14.3% | 3,373 | -51.6% | 0.00% | – |
| Q4 2022 | $7 | -100.0% | 6,964 | -36.5% | 0.00% | – |
| Q3 2022 | $25,000 | +2400.0% | 10,968 | +3721.6% | 0.00% | – |
| Q1 2022 | $1,000 | -93.3% | 287 | -86.7% | 0.00% | – |
| Q4 2020 | $15,000 | -53.1% | 2,166 | -45.8% | 0.00% | – |
| Q3 2020 | $32,000 | -84.7% | 3,993 | -83.4% | 0.00% | – |
| Q4 2019 | $209,000 | +20800.0% | 24,027 | +10167.9% | 0.00% | – |
| Q2 2019 | $1,000 | – | 234 | +70.8% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 137 | -99.7% | 0.00% | -100.0% |
| Q3 2018 | $354,000 | +74.4% | 54,541 | +105.6% | 0.00% | 0.0% |
| Q2 2018 | $203,000 | +141.7% | 26,528 | +602.9% | 0.00% | -75.0% |
| Q1 2018 | $84,000 | +147.1% | 3,774 | +37.5% | 0.00% | +300.0% |
| Q4 2017 | $34,000 | – | 2,745 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 10,230,349 | $63,428,000 | 41.36% |
| TRV GP III, LLC | 3,048,780 | $18,902,000 | 9.26% |
| Omega Fund Management, LLC | 1,059,930 | $6,572,000 | 1.39% |
| Alambic Investment Management, L.P. | 50,622 | $314,000 | 0.13% |
| Spark Investment Management LLC | 244,300 | $1,514,000 | 0.07% |
| ALGERT GLOBAL LLC | 14,182 | $88,000 | 0.05% |
| Redmile Group, LLC | 254,590 | $1,578,000 | 0.05% |
| Granahan Investment Management | 125,533 | $778,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 38,602 | $239,000 | 0.02% |
| Frontier Wealth Management LLC | 27,099 | $168,000 | 0.02% |